HuhJ, 2012.Epidemiologic overview of malignant lymphoma,Korean J Hematol 47 92 -104
PervezS.,Non-Hodgkin Lymphoma, 2012.NHL) in Pakistan,Int J Mol Cell Med 1 62 -3
Hemandez-llizalituriFJ,DeebG,ZinzaniPL,PileriSA,MalikF,MaconWR, 2011.Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-celllike phenotype,Cancer 117 5058 -66
MenonMP,PittalugaS,JaffeES, 2012.The histological and biological spectrum of diffuse large B-cell lymphoma in the WHO classification,Cancer J 18 411 -20
GualcoG,WeissLM,HarringtonWJ, 2009.Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome,Am J Surg Pathol 33 1815 -22
GuoY,TakeuchiI,KarnanS,MiyataT,OshimaK,SetoM, 2014.Array-comparative genomic hybridization profiling of immunohistochemical subgroups of diffuse large B-cell lymphoma shows genomic alterations,Cancer Sci 105 481 -9
BahadirB,BehzatogluK,BektasS,BozkurtER,OzdamarSO, 2009.CD10 expression in urothelial carcinoma of the badder,Diagn Pathol 4 38 -
ShafferAL,EmreNCT,RomesserPB,StaudtLM, IRF4., -
ChenY,HanT,IqbalJ,IronsR,ChanWC,ZhuX, 2010.Diffuse large B-cell lymphoma in Chinese patients immuno-phenotypic and cytogenetic analysis of 124 cases,Am J Cli Pathol 133 305 -13
HabaraT,SatoY,TakataK,IwakiN,OkumuraH,SanobeH, 2012.Germinal center B-cell-like versus non-germinal center B-cell-like as important prognostic factor for localized nodal DLBCL,J Clin Exp Hematopathol 52 91 -9
YangZZ,NovakAJ,ZiesmerSC,WitzigTE,AnsellSM, 2007.CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells,Blood 110 2537 -44
de LevalL,RickmanDS,ThielenC,ReyniesA,HuangYL,DelsolG, 2007.The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells,Blood 1 4952 -63
NymanH,JerkemanM,Karjalainen-LindsbergM,BanhamAH,LeppaS., 2009.Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP,Mod Pathol 22 1094 -101
HuangY,YeS,CaoY,LiZ,HuangJ,HuangH,CaiM,LuoR,LinT., 2012.Outcome of R-CHOP or CHOP regimen for germinal center and nongerminal center subtypes of diffuse large B-cell lymphoma of Chinese patients,Sci World J 8971 -8
Batlle-LópezA,GonzálezDV,MazorraF,MalatxeberriaS,SáezA,MontalbanC, 2016.Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker,Oncotarget 5 18036 -49
HwangHS,YoonDH,SuhC,ParkCS,HuhJ, 2013.Prognostic value of immunohistochemical algorithms in gastrointestinal diffuse large B-cell lymphoma,Blood Res 48 266 -73
DaviesAJ,RosenwaldA,WrightG,LeeA,LastKW,WeisenburgerDD, 2007.Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms,Br J Haematol 136 286 -93
ViscoC,LiY,Xu-MonetteZY,MirandaRN,GreenTM,LiY, 2012.Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: A report from the International DLBCL rituximab-CHOP consortium program study,Leukemia 26 2103 -13